Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

INTRODUCTION: Reverse shoulder arthroplasty (rTSA) is increasingly performed in elderly patients; however, the influence of advancing age and comorbidity on revision, medical complications, and mortality remains poorly defined. This study aims to use population reflective data in the National Joint Registry (NJR) to assess the outcomes of those ≥80 years old having an rTSA. METHODS: Elective rTSA procedures performed between 2012 and 2022 in patients aged ≥80 years were identified from the NJR and linked to Hospital Episode Statistics for England. The primary outcome was revision surgery. Secondary outcomes included 30-day medical complications, length of stay, and mortality. Associations with age, sex, and ASA grade were assessed using survival and regression analyses, with subgroup analyses in patients aged ≥85 and ≥90 years. RESULTS: A total of 6,988 patients aged ≥80 years were included. Revision rates were low (1.4% at 1 year,2.32% at 5 years and 3.35% at 9 years), with male sex associated with a higher risk of revision (HR 3.45, 95% CI 2.47-4.81). Increasing age was associated with a reduced likelihood of revision (HR 0.89 per year 95% CI 0.84-0.96, p=0.001), likely reflecting competing mortality and higher thresholds for reoperation. In contrast, medical complications occurred in 8.9% of patients aged ≥80 years, rising to 16.4% in those aged ≥90 years. Each additional year of age was associated with increased odds of a medical complication (OR 1.04, 95% CI 1.01-1.07), with substantially higher risk in patients with ASA III-IV. One-year mortality increased from 3.3% in patients aged ≥80 years to 8.2% in those aged ≥90 years. CONCLUSION: While revision following rTSA is uncommon in very elderly patients, medical complications and mortality increase substantially with advancing age and comorbidity. Chronological age alone should not preclude consideration of rTSA, but these risks should be central to pre-operative counselling and shared decision making.

More information Original publication

DOI

10.1016/j.jse.2026.06.013

Type

Journal article

Publication Date

2026-06-24T00:00:00+00:00

Keywords

elderly patients, frailty, national joint registry, reverse shoulder arthroplasty, shoulder arthroplasty, shoulder replacement